News Scientific study suggests that mesoporous silica particles (MSPs) interact with the lipid digestion and absorption pathways to reduce calorific uptake By Sana | News | No Comments
News Sigrid Therapeutics granted European patent covering the use of porous SiPore® silica particles as pharmaceutical or dietary active ingredients By Sana | News | No Comments
News Sigrid Therapeutics’ Co-founder & CEO Sana Alajmovic named Sweden’s Female Founder of the Year 2021 By Sana | News | No Comments
News Unique Swedish concept for two of the world’s biggest health challenges closer to breakthrough By Sana | News | No Comments
News Sigrid Therapeutics Prevents Type 2 Diabetes Using Silica Powder in the Gut By Sana | News | No Comments
